Reduction in self-monitoring of blood glucose in type 2 diabetes: an observational controlled study in east London by John Robson, Hannah Smithers, Tahseen Chowdhury, Philip Bennett-Richards, David Keene, Isabel Dostal, Rohini Mathur, Jack Dunne, Sally Hull, and Kambiz Boomla BJGP Volume 65(633):e256-e263 March 30, 2015 ©2015 by British Journal of General Practice

Proportion of patients with type 2 diabetes on no treatment or metformin only, who are prescribed self-monitoring blood glucose. Proportion of patients with type 2 diabetes on no treatment or metformin only, who are prescribed self-monitoring blood glucose. The red arrow marks the start of the intervention.CCG = clinical commissioning group. John Robson et al. Br J Gen Pract 2015;65:e256-e263 ©2015 by British Journal of General Practice

Proportion of patients with type 2 diabetes, excluding those treated with insulin, who are prescribed self-monitoring blood glucose. Proportion of patients with type 2 diabetes, excluding those treated with insulin, who are prescribed self-monitoring blood glucose. The red arrow marks the start of the intervention.CCG = clinical commissioning group. John Robson et al. Br J Gen Pract 2015;65:e256-e263 ©2015 by British Journal of General Practice

Total diabetes (type 1 and type 2, including insulin) cost per capita for self-monitoring strips (data for London 2013 was not available). Total diabetes (type 1 and type 2, including insulin) cost per capita for self-monitoring strips (data for London 2013 was not available). The red arrow marks the start of the intervention.CCG = clinical commissioning group. John Robson et al. Br J Gen Pract 2015;65:e256-e263 ©2015 by British Journal of General Practice